CLDN5 and inflammatory bowel disease: In both inflammatory bowel disease (IBD) patients and dextran sodium sulfate (DSS)-induced colitis models, elevated interleukin-21 (IL-21) levels are associated with Cldn5 downregulation, mediated by upregulation of miR-423-5p [153].